大家好，“外企头条”栏目又跟大家见面了。今天的主要内容有：

　　必和必拓2017财年表现强劲；

　　生命科学推动默克有机销售增长2.3%；

　　沃尔玛中国第二财季营收增长2.1%；

　　参加编程马拉松提高求职竞争力。

　　请看详细报道↓↓

　　必和必拓2017财年表现强劲

　　BHP had a very strong financial performance in FY2017

　　必和必拓近日公布2017财报（截至6月30日），可分配利润达59亿美元，当期息税折旧摊销前利润（EBITDA）为203亿美元。此外，集团因生产效率的提升所带来的收益达13亿美元，完成既定目标。

　　BHP reported financial results for the year ended 30 June. Attributable profit of US$5.9 billion, underlying EBITDA of US$20.3 billion for the 2017 financial year. Productivity gains of US$1.3 billion was achieved for the period.

　　得益于大宗商品价格的上涨、强劲的经营业绩和资本效率的持续提升，集团当期实现了168亿美元的经营净现金流，以及126亿美元的自由现金流，帮助集团减少了近100亿美元的净负债 。

　　Net operating cash flow of US$16.8 billion and free cash flow of US$12.6 billion were underpinned by higher commodity prices, strong operating performance and improved capital productivity, which help reduce net debt by nearly US$10 billion.

　　2017财年集团派发的总股息为44亿美元，即在50%最低派息额政策之上的额外派息共11亿美元。每股43美分的期末股息将从自由现金流中支付。

　　The Board has determined to pay a final dividend of 43 US cents per share which is covered by free cash flow generated in the current period. Total dividends of US$4.4 billion determined for the 2017 financial year include US$1.1 billion in additional amounts over and above the 50% minimum payout policy.

　　必和必拓集团现在专注于低成本高回报的挖潜项目，从而使集团能够将资本支出减少70%以上。得益于集团一级资产组合生产效率的提升所带来的收益，集团资本回报率提升到10%。

　　BHP has shifted its focus to low-cost, high-return latent capacity projects which has allowed us to reduce capital expenditure by over 70%. Productivity gains across our simpler portfolio of tier one assets increased our return on capital to 10%.

　　默克为其未来发展制定方向

　　Merck Sets Course for Future Growth

　　默克日前宣布2017年第二季度的销售额实现了增长，但扣除非经常性损益项目前的息税折旧及摊销前利润与去年同期相比有所下滑。

　　Merck reported recently an increase in sales in the second quarter of 2017 along with a decline in EBITDA pre exceptionals compared with the year-earlier period.

　　“通过专注于发展创新药物，我们的医药健康业务取得了很多重大突破。我们将在整合西格玛奥德里奇的道路上继续前进。同时，此前过高的液晶业务市场份额也下降到了正常的水平。”默克执行董事会主席兼首席执行官欧思明说。

　　“By focusing on innovative medicines, we made very important advances in Healthcare. We also continued to make headway with the integration of Sigma-Aldrich. At the same time, we are seeing a normalization of our unusually high market shares in the Liquid Crystals business,” said Stefan Oschmann, CEO and Chairman of the Executive Board of Merck.

　　2017年第二季度，默克的净销售额达到了39亿欧元，较去年第二季度取得了2.3%的增长。

　　In the second quarter, Merck increased its net sales by 2.3% to